[Experience and perspectives in the use of liposomal form of antineoplastic drugs in clinical oncology].
Shal'kov
Iu L
IuL
Dudnichenko
A S
AS
Krasnopol'skiĭ
Iu M
IuM
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D004337:Drug Carriers; D005260:Female; D006801:Humans; D008081:Liposomes; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes
Opyt i perspektivy ispol'zovaniia liposomal'noĭ formy protivoopukholevykh preparatov v klinicheskoĭ onkologii.